The Conversation (0)
Supreme Pharmaceuticals Inc. (OTCBB:SPRWF,TSXV:SL) has entered into negotiations to acquire a business and its producing medical marijuana facility. This is in addition to the South Okanagan producing facility currently under evaluation. There is no guarantee an agreement will be reached, but both parties have agreed to a 45-day negotiating period. As quoted in the press release:
Supreme Pharmaceuticals Inc. (OTCBB:SPRWF,TSXV:SL) has entered into negotiations to acquire a business and its producing medical marijuana facility. This is in addition to the South Okanagan producing facility currently under evaluation. There is no guarantee an agreement will be reached, but both parties have agreed to a 45-day negotiating period. As quoted in the press release:
If Supreme is successful in securing an agreement with this producing company, of which there is no assurance, it will apply for a commercial MMPR licence in regard to this facility, and there is no guarantee that such a license will be granted. The facility is located in the lower mainland of British Columbia and currently operates under MMAP licensing; the business has been producing medical marijuana for several years on wholly owned property.
Supreme CEO, David Stadnyk, said:
Our goal is to secure several medical marijuana producing facilities, each with a MMPR license. There is no assurance that we will be able to secure such facilities. This is a critical year for MMPR licences and we plan on making several applications to Health Canada.
Click here to read the full press release:
